Pangaea Oncology, S.A. (BME:PANG)

Pangaea Oncology Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 26, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	58	54	50	35	27	29
Market Cap Growth	-14.35%	8.35%	41.34%	30.94%	-5.88%	-1.37%
Enterprise Value	61	52	40	35	30	32
Last Close Price	1.70	1.84	1.64	1.55	1.58	1.68
Forward PE	-	-	97.14	-	-	-
PS Ratio	3.60	5.44	7.49	5.27	4.38	5.22
PB Ratio	3.18	2.88	2.17	2.51	3.25	3.45
P/TBV Ratio	5.09	4.88	2.39	1.69	4.11	4.55
PEG Ratio	2.74	2.74	2.74	8.85	-	-
EV/Sales Ratio	4.26	5.18	6.00	5.25	4.87	5.83
Debt / Equity Ratio	0.23	0.18	0.11	0.25	0.52	0.45
Asset Turnover	0.55	0.35	0.27	0.36	0.37	0.30
Inventory Turnover	3.84	5.05	5.96	3.38	4.28	3.74
Quick Ratio	1.04	1.27	4.74	2.20	1.09	0.97
Current Ratio	1.16	1.34	4.89	2.36	1.19	1.02
Return on Equity (ROE)	-29.97%	-22.89%	-14.66%	-5.73%	-21.09%	-57.57%
Return on Assets (ROA)	-9.44%	-7.52%	-6.85%	-2.12%	-6.96%	-8.86%
Return on Capital (ROIC)	-11.48%	-9.02%	-7.81%	-2.65%	-9.54%	-13.02%
Earnings Yield	-9.14%	-8.59%	-5.42%	-1.81%	-6.49%	-16.86%
FCF Yield	-4.96%	-4.90%	-7.39%	-7.14%	-7.35%	-8.35%
Buyback Yield / Dilution	-3.35%	0.98%	-35.11%	-20.34%	-10.89%	-28.80%

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.